Sign In
Buy ANVS
$1.77
+0.0200 (+1.14%)
At Close: Jun 22, 2026
New York, New York--(Newsfile Corp. - September 15, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities
New York, New York--(Newsfile Corp. - September 14, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a
New York, New York--(Newsfile Corp. - September 13, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Annovis Bio, Inc. ("Annovis" or the "Company") (NYSE: ANVS) and c
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Annovis Bio, Inc. (ANVS)
11:00am, Monday, 13'th Sep 2021
LOS ANGELES, Sept. 13, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming October 18, 2021 deadline to file a lead plaintiff motion in the class action fil
CLASS ACTION UPDATE for OTLY, ANVS and SAVA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
11:30am, Sunday, 12'th Sep 2021
NEW YORK, NY / ACCESSWIRE / September 12, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareho
CLASS ACTION UPDATE for ATVI, YALA and ANVS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
10:30am, Sunday, 12'th Sep 2021
NEW YORK, NY / ACCESSWIRE / September 12, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareho
New York, New York--(Newsfile Corp. - September 10, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities
Annovis Bio to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
09:00am, Friday, 10'th Sep 2021
BERWYN, Pa., Sept. 10, 2021 /PRNewswire/ -- Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson
BENSALEM, Pa., Sept. 9, 2021 /PRNewswire/ -- Law Offices of Howard G.
ANVS Investor Alert: Class Action Lawsuit Filed
09:45am, Thursday, 09'th Sep 2021
Boston, Massachusetts--(Newsfile Corp. - September 9, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Annovis Bio, Inc. (NYSE: ANVS)
NEW YORK, Sept. 8, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class act
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Annovis Bio, Inc. (ANVS) Investors
12:05pm, Tuesday, 07'th Sep 2021
LOS ANGELES, Sept. 7, 2021 /PRNewswire/ -- The Law Offices of Frank R.
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BLCT, ANVS and VIEW
11:20am, Sunday, 05'th Sep 2021
NEW YORK, NY / ACCESSWIRE / September 5, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companie
SHAREHOLDER ALERT: BZ PHG ANVS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
10:30am, Sunday, 05'th Sep 2021
NEW YORK, NY / ACCESSWIRE / September 5, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Annovis Bio, Inc. - ANVS
04:15am, Sunday, 05'th Sep 2021
NEW YORK, Sept. 5, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Annovis Bio, Inc. ("Annovis" or the "Company") (NYSE: ANVS).
